Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07223580

A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi

Evaluating The Role Of Corticosteroids In Post-Ureteroscopy Recovery For Urinary Calculi

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications

Conditions

Interventions

TypeNameDescription
DRUGCorticosteroidIn addition to the standard of care postoperative ureteroscopy medication, participants will be given prednisone 25 mg orally, once a day for 5 days post-surgery.
OTHERPlaceboIn addition to the standard of care postoperative ureteroscopy medication, participants will be given a placebo pill orally, once a day for 5 days post-surgery.

Timeline

Start date
2026-01-23
Primary completion
2027-01-01
Completion
2027-12-01
First posted
2025-11-03
Last updated
2026-02-03

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07223580. Inclusion in this directory is not an endorsement.

A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi (NCT07223580) · Clinical Trials Directory